I know their valuation is largely based on prospects for Feraheme as a treatment for iron-deficiency anemia, but included AMAG since they have a diagnostic imaging business. Also HealthShares Diagnostics actually held AMAG as position when they rebalanced their funds last October: biz.yahoo.com/indexuni...
The new stocks being adding to HHD are:
Abaxis Affymetrix AMAG Pharmaceuticals AngioDynamics Enzo Biochem Given Imaging Merit Medical Systems Neogen Corp. Nighthawk Radiology Holdings Quidel Corp. SonoSite TomoTherapy TOPCON Corp.
Create Your Own Diagnostics ETF [View article]
biz.yahoo.com/indexuni...
The new stocks being adding to HHD are:
Abaxis
Affymetrix
AMAG Pharmaceuticals
AngioDynamics
Enzo Biochem
Given Imaging
Merit Medical Systems
Neogen Corp.
Nighthawk Radiology Holdings
Quidel Corp.
SonoSite
TomoTherapy
TOPCON Corp.